API Raw Material CAS 70359 -46-5 99% Brimonidine L-Tartrate D-Tartrate

China API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate, Find details about China Brimonidine Tartrate, Brimonidine Tartrate 99% from API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate

Model NO.
BT
Trademark
Greenway
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000
Model NO.
BT
Trademark
Greenway
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
Jiangsu, China
HS Code
2942000000

API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate

API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
Product Description of API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
 
{Product Name}:Brimonidine Tartrate
{Other Name}:Brimonidine L-tartrate/D-tartrate
{Test Method.}: HPLC
{Appearance}: White Powder
{Specification}:99%
{MOQ}: 1kg

Brimonidine Tartrate is a drug used to treat open-angle glaucoma or ocular hypertension.
It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form.



API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-TartrateAPI Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
Application

It is used to treat open-angle glaucoma, ocular hypertension, and to increase intraocular pressure after laser surgery in the anterior segment of the eye.


API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate




API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate
API Raw Material CAS 70359-46-5 99% Brimonidine L-Tartrate D-Tartrate

Send us an inquiry